N-(3-(DIFLUOROMETHYL)PHENYL)-N,O-DIMETHYLHYDROXYLAMINE, 95.0%, 2g

N,N'-Diphenyl-N,N'-di(p-tolyl)benzidine>98.0%(GC)1g

4-Chloro-1H-pyrazole-3-carboxylic acid, 95.0%, 25g

2-Bromoethylisocyanate, 5g

4-(Aminomethyl)pyridin-2(1H)-one hydrochloride, 95.0%, 5g

Syringe filters Millex® HPF Hydrophilic polytetrafluoroethylene (PTFE), 0,2 µm, 50 Piece(s)

Plan PLPHi S40x/0.65 phase contrast IOS infinity corrected objective

(3aS,4R,7aS)-2-(tert-Butoxycarbonyl)octahydro-1H-isoindole-4-carboxylic acid, 98+%, 2g

1-Bromo-5-fluoro-3-iodo-2-methylbenzene, 98%, 500mg

(1S,4S)-2-Methyl-2,5-diazabicyclo[2.2.1]heptane dihydrochloride, 97%, 100mg

6-BROMO-3-IODOPYRIDIN-2-AMINE, 97%, 100mg

6-Bromo-7-fluoroisoquinolin-1(2H)-one, 97%, 500mg

2-Bromo-1-(bromomethyl)-3-iodobenzene, 95.0%, 100mg